DOYLE MITTIE (Chief Medical Officer) sold 1.4% of their position (679.00 shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/1/2026ACC: 0001918845-26-000016
Officer· Chief Medical Officer
Since Feb 2026
-679.00
Net shares
Net seller
$10.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
679.00 acquired · 1.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+679.00
Price / share
$8.04
Trade value
$5.46K
% of position
1.4%
5/28/2026
47.12K→47.80K
Common Stock
Direct
Shares
−679.00
Price / share
$16.00
Trade value
$10.86K
% of position
1.4%
5/28/2026
47.80K→47.12K
Total
Net shares
+0.00
Net value
-$5.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/28/2026 | M · Option Exercise | +679.00 | $8.04 | $5.46K | 1.4% | 47.12K | 47.80K |
| Common Stock Direct | 5/28/2026 | S · Sale | −679.00 | $16.00 | $10.86K | 1.4% | 47.80K | 47.12K |
| Total | +0.00 | -$5.40K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
679.00 shares
Shares
−679.00
Strike price
8.04
Held after
118.32K
Exercisable
—
5/28/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock679.00 shares | 5/28/2026 | M · Option Exercise | −679.00 | 8.04 | — | 118.32K |